revel study: continuum of care in metastatic nsclc with cyramza | crsf
Published 4 months ago • 46 plays • Length 11:05Download video MP4
Download video MP3
Similar videos
-
2:37
exploratory analysis of frontline therapies in revel: phase 3 trial of ramucirumab in nsclc
-
2:26
the revel study in lung cancer
-
6:18
treating nsclc with ramucirumab: the revel trial
-
4:16
ramucirumab data for lung cancer
-
2:35
exploratory analysis of frontline therapies in revel: a phase 3 trial of ramucirumab in nsclc
-
35:44
panel discussion | dr ullas batra | hidden egfr threat role of amivantamab
-
4:14
clinical implications of the revel trial in nsclc
-
5:13
the revel trial and subanalysis
-
6:11
patient selection for ramucirumab in nsclc
-
1:19
what are my options for treatment and management of small cell lung cancer (sclc)?
-
56:45
dr. triparna sen: small cell lung cancer research
-
3:44
early detection of lung cancer: what you need to know.
-
2:25
prophylactic cranial irradiation for extensive stage small cell lung cancer
-
1:05
how can i reach a specialist lung cancer nurse? | lung foundation australia
-
17:00
emerging approaches to small cell lung cancer | 2022 evolution conference
-
2:24
reinvigorating the immune system to find new ways to cure cancer
-
2:03
chemoradiation and immunotherapy for patients with small cell lung cancer
-
6:22
diagnosis and treatment of small cell lung cancer
-
7:28
does cyramza (ramucirumab) make difference for second line treatment?